The elevated decorin levels indicate stronger stromal structure maintenance and tumour-controlling environmental changes that match decorin’s proven ability to block TGF-β signalling, receptor tyrosine kinase activity and angiogenesis in a tumour stroma. This evidence concerns the gene NTRK1 and neoplasm.